Portfolio comparison
Gilead Sciences Inc vs Dexcom
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Gilead Sciences Inc
Patents indexed
3
Year range
2013 – 2017
Most recent
2017
biotechpharmaceutical
Top Patents3 enriched
US 8592397· 2013
How Gilead Made a Stable HIV Pill Combining Two Medicines
US 9216996· 2015
Gilead's Chemical Compounds for Treating HIV Infections
US 9744181· 2017
How Gilead Stabilized the HIV Combination Pill Truvada
Activity by Decade
2010s3
Company B
Dexcom
Patents indexed
3
Year range
2016 – 2022
Most recent
2022
softwarebiotechtelecommunicationsconsumer_electronicsmedical_devices
Top Patents3 enriched
US 9282925· 2016
How Glucose Sensors Check Their Own Reliability for Insulin Pumps
US 11382539· 2022
A Catheter That Measures Glucose While Delivering Medication
US 20230263439
How a Sensor Checks Itself for Accuracy Using Other Body Data
Activity by Decade
2010s1
2020s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.